263 related articles for article (PubMed ID: 24996770)
1. Complement modulation in solid-organ transplantation.
Touzot M; Obada EN; Beaudreuil S; François H; Durrbach A
Transplant Rev (Orlando); 2014 Jul; 28(3):119-25. PubMed ID: 24996770
[TBL] [Abstract][Full Text] [Related]
2. Role of complement and perspectives for intervention in transplantation.
Chen G; Chen S; Chen X
Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
[TBL] [Abstract][Full Text] [Related]
3. Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders.
Risitano AM
Immunobiology; 2012 Nov; 217(11):1080-7. PubMed ID: 22964233
[TBL] [Abstract][Full Text] [Related]
4. Role of complement in graft rejection after organ transplantation.
Bos IG; Ten Berge IJ; Hack CE
Transfus Med Rev; 2002 Jul; 16(3):251-64. PubMed ID: 12075562
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of complement inhibitors in transplantation.
Frémeaux-Bacchi V; Legendre CM
Kidney Int; 2015 Nov; 88(5):967-73. PubMed ID: 26376132
[TBL] [Abstract][Full Text] [Related]
6. The role of complement in antibody-mediated rejection in kidney transplantation.
Stegall MD; Chedid MF; Cornell LD
Nat Rev Nephrol; 2012 Nov; 8(11):670-8. PubMed ID: 23026942
[TBL] [Abstract][Full Text] [Related]
7. Learnings from over 25 years of PNH experience: the era of targeted complement inhibition.
Heitlinger E
Blood Rev; 2013 Dec; 27 Suppl 1():S1-6. PubMed ID: 24331206
[TBL] [Abstract][Full Text] [Related]
8. Complement inhibition as potential new therapy for antibody-mediated rejection.
Eskandary F; Wahrmann M; Mühlbacher J; Böhmig GA
Transpl Int; 2016 Apr; 29(4):392-402. PubMed ID: 26474721
[TBL] [Abstract][Full Text] [Related]
9. Humoral immunity and antibody-mediated rejection in solid organ transplantation.
Montgomery RA; Cozzi E; West LJ; Warren DS
Semin Immunol; 2011 Aug; 23(4):224-34. PubMed ID: 21958960
[TBL] [Abstract][Full Text] [Related]
10. Complement and hyper acute rejection.
Al-rabia MW
Saudi J Kidney Dis Transpl; 2009 May; 20(3):362-9. PubMed ID: 19414935
[TBL] [Abstract][Full Text] [Related]
11. Modifiers of complement activation for prevention of antibody-mediated injury to allografts.
Hughes PD; Cohney SJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):425-33. PubMed ID: 21681097
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
Riedl M; Fakhouri F; Le Quintrec M; Noone DG; Jungraithmayr TC; Fremeaux-Bacchi V; Licht C
Semin Thromb Hemost; 2014 Jun; 40(4):444-64. PubMed ID: 24911558
[TBL] [Abstract][Full Text] [Related]
13. Eculizumab in renal transplantation.
Legendre C; Sberro-Soussan R; Zuber J; Rabant M; Loupy A; Timsit MO; Anglicheau D
Transplant Rev (Orlando); 2013 Jul; 27(3):90-2. PubMed ID: 23747093
[TBL] [Abstract][Full Text] [Related]
14. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
15. The role of complement in the early immune response to transplantation.
Sacks SH; Zhou W
Nat Rev Immunol; 2012 May; 12(6):431-42. PubMed ID: 22627861
[TBL] [Abstract][Full Text] [Related]
16. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.
Halstead SK; Zitman FM; Humphreys PD; Greenshields K; Verschuuren JJ; Jacobs BC; Rother RP; Plomp JJ; Willison HJ
Brain; 2008 May; 131(Pt 5):1197-208. PubMed ID: 18184663
[TBL] [Abstract][Full Text] [Related]
17. Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.
Nester CM; Brophy PD
Curr Opin Pediatr; 2013 Apr; 25(2):225-31. PubMed ID: 23486421
[TBL] [Abstract][Full Text] [Related]
18. Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics.
Melis JP; Strumane K; Ruuls SR; Beurskens FJ; Schuurman J; Parren PW
Mol Immunol; 2015 Oct; 67(2 Pt A):117-30. PubMed ID: 25697848
[TBL] [Abstract][Full Text] [Related]
19. The renaissance of complement therapeutics.
Ricklin D; Mastellos DC; Reis ES; Lambris JD
Nat Rev Nephrol; 2018 Jan; 14(1):26-47. PubMed ID: 29199277
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of rejection: role of complement.
Farrar CA; Sacks SH
Curr Opin Organ Transplant; 2014 Feb; 19(1):8-13. PubMed ID: 24316762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
